$ENZN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ENZON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ENZON PHARMACEUTICALS, INC.. Get notifications about new insider transactions in ENZON PHARMACEUTICALS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 19 2004 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Sell | S | 14.43 | 300 | 4,329 | 16,745 | 17 K to 16.7 K (-1.76 %) |
May 19 2004 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Sell | S | 14.45 | 1,000 | 14,450 | 17,045 | 18 K to 17 K (-5.54 %) |
May 19 2004 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Sell | S | 14.46 | 421 | 6,088 | 18,045 | 18.5 K to 18 K (-2.28 %) |
May 19 2004 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Sell | S | 14.47 | 133 | 1,925 | 18,466 | 18.6 K to 18.5 K (-0.72 %) |
May 19 2004 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Buy | M | 5.50 | 17,320 | 95,260 | 18,599 | 1.3 K to 18.6 K (+1,354.18 %) |
Apr 05 2004 | ENZN | ENZON PHARMACEUTIC ... | ZUERBLIS KENNETH J | V.P., Finance, CFO | Option Exercise | A | 15.13 | 50,000 | 756,500 | 50,000 | |
Apr 05 2004 | ENZN | ENZON PHARMACEUTIC ... | GRAU ULRICH M | Chief Scientific Of ... | Option Exercise | A | 15.13 | 50,000 | 756,500 | 50,000 | |
Apr 05 2004 | ENZN | ENZON PHARMACEUTIC ... | GRAU ULRICH M | Chief Scientific Of ... | Option Exercise | A | 15.13 | 50,000 | 756,500 | 50,000 | |
Apr 01 2004 | ENZN | ENZON PHARMACEUTIC ... | PARKINSON ROBERT L JR | Director | Option Exercise | M | 0.00 | 293 | 0 | 0 | |
Apr 01 2004 | ENZN | ENZON PHARMACEUTIC ... | PARKINSON ROBERT L JR | Director | Option Exercise | M | 0.00 | 301 | 0 | 0 | |
Apr 01 2004 | ENZN | ENZON PHARMACEUTIC ... | PARKINSON ROBERT L JR | Director | Option Exercise | M | 0.00 | 359 | 0 | 0 | |
Apr 01 2004 | ENZN | ENZON PHARMACEUTIC ... | PARKINSON ROBERT L JR | Director | Option Exercise | M | 0.00 | 485 | 0 | 0 | |
Apr 01 2004 | ENZN | ENZON PHARMACEUTIC ... | PARKINSON ROBERT L JR | Director | Buy | M | 0.00 | 1,438 | 0 | 6,738 | 5.3 K to 6.7 K (+27.13 %) |
Apr 01 2004 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Option Exercise | M | 0.00 | 335 | 0 | 0 | |
Apr 01 2004 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Option Exercise | M | 0.00 | 344 | 0 | 0 | |
Apr 01 2004 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Option Exercise | M | 0.00 | 399 | 0 | 0 | |
Apr 01 2004 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Option Exercise | M | 0.00 | 441 | 0 | 0 | |
Apr 01 2004 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Buy | M | 0.00 | 1,519 | 0 | 13,807 | 12.3 K to 13.8 K (+12.36 %) |
Apr 01 2004 | ENZN | ENZON PHARMACEUTIC ... | DIXON ROSINA B | Director | Option Exercise | M | 0.00 | 293 | 0 | 0 | |
Apr 01 2004 | ENZN | ENZON PHARMACEUTIC ... | DIXON ROSINA B | Director | Option Exercise | M | 0.00 | 301 | 0 | 0 | |
Apr 01 2004 | ENZN | ENZON PHARMACEUTIC ... | DIXON ROSINA B | Director | Option Exercise | M | 0.00 | 359 | 0 | 0 | |
Apr 01 2004 | ENZN | ENZON PHARMACEUTIC ... | DIXON ROSINA B | Director | Option Exercise | M | 0.00 | 485 | 0 | 0 | |
Apr 01 2004 | ENZN | ENZON PHARMACEUTIC ... | DIXON ROSINA B | Director | Buy | M | 0.00 | 719 | 0 | 37,605 | 36.9 K to 37.6 K (+1.95 %) |
Apr 01 2004 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Option Exercise | M | 0.00 | 335 | 0 | 0 | |
Apr 01 2004 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Option Exercise | M | 0.00 | 387 | 0 | 0 | |
Apr 01 2004 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Option Exercise | M | 0.00 | 399 | 0 | 0 | |
Apr 01 2004 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Option Exercise | M | 0.00 | 485 | 0 | 0 | |
Apr 01 2004 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Buy | M | 0.00 | 1,606 | 0 | 9,272 | 7.7 K to 9.3 K (+20.95 %) |
Apr 01 2004 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Option Exercise | M | 0.00 | 293 | 0 | 0 | |
Apr 01 2004 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Option Exercise | M | 0.00 | 258 | 0 | 0 | |
Apr 01 2004 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Option Exercise | M | 0.00 | 359 | 0 | 0 | |
Apr 01 2004 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Option Exercise | M | 0.00 | 441 | 0 | 0 | |
Apr 01 2004 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Buy | M | 0.00 | 676 | 0 | 1,279 | 603 to 1.3 K (+112.11 %) |
Feb 10 2004 | ENZN | ENZON PHARMACEUTIC ... | HIGGINS ARTHUR J | Chairman, President ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
Feb 10 2004 | ENZN | ENZON PHARMACEUTIC ... | HIGGINS ARTHUR J | Chairman, President ... | Option Exercise | A | 14.15 | 100,000 | 1,415,000 | 100,000 | |
Feb 10 2004 | ENZN | ENZON PHARMACEUTIC ... | GRAU ULRICH M | Chief Scientific Of ... | Option Exercise | A | 0.00 | 12,500 | 0 | 12,500 | |
Feb 10 2004 | ENZN | ENZON PHARMACEUTIC ... | GRAU ULRICH M | Chief Scientific Of ... | Option Exercise | A | 14.15 | 50,000 | 707,500 | 50,000 | |
Feb 10 2004 | ENZN | ENZON PHARMACEUTIC ... | GRAU ULRICH M | Chief Scientific Of ... | Option Exercise | A | 0.00 | 12,500 | 0 | 12,500 | |
Feb 10 2004 | ENZN | ENZON PHARMACEUTIC ... | GRAU ULRICH M | Chief Scientific Of ... | Option Exercise | A | 14.15 | 50,000 | 707,500 | 50,000 | |
Feb 10 2004 | ENZN | ENZON PHARMACEUTIC ... | ZUERBLIS KENNETH J | Chief Financial Off ... | Option Exercise | A | 0.00 | 12,500 | 0 | 12,500 | |
Feb 10 2004 | ENZN | ENZON PHARMACEUTIC ... | ZUERBLIS KENNETH J | Chief Financial Off ... | Option Exercise | A | 14.15 | 50,000 | 707,500 | 50,000 | |
Jan 15 2004 | ENZN | ENZON PHARMACEUTIC ... | GRAU ULRICH M | Chief Scientific Of ... | Grant | A | 0.00 | 40,000 | 0 | 40,381 | 381 to 40.4 K (+10,498.69 %) |
Jan 05 2004 | ENZN | ENZON PHARMACEUTIC ... | DIXON ROSINA B | Director | Option Exercise | M | 2.75 | 10,000 | 27,500 | 16,664 | |
Jan 05 2004 | ENZN | ENZON PHARMACEUTIC ... | DIXON ROSINA B | Director | Option Exercise | A | 12.15 | 5,000 | 60,750 | 5,000 | |
Jan 05 2004 | ENZN | ENZON PHARMACEUTIC ... | DIXON ROSINA B | Director | Option Exercise | A | 0.00 | 293 | 0 | 293 | |
Jan 05 2004 | ENZN | ENZON PHARMACEUTIC ... | DIXON ROSINA B | Director | Buy | M | 2.75 | 10,000 | 27,500 | 36,886 | 26.9 K to 36.9 K (+37.19 %) |
Jan 05 2004 | ENZN | ENZON PHARMACEUTIC ... | DIXON ROSINA B | Director | Option Exercise | M | 2.75 | 10,000 | 27,500 | 16,664 | |
Jan 05 2004 | ENZN | ENZON PHARMACEUTIC ... | DIXON ROSINA B | Director | Option Exercise | A | 12.15 | 5,000 | 60,750 | 5,000 | |
Jan 05 2004 | ENZN | ENZON PHARMACEUTIC ... | DIXON ROSINA B | Director | Option Exercise | A | 0.00 | 293 | 0 | 293 | |
Jan 05 2004 | ENZN | ENZON PHARMACEUTIC ... | DIXON ROSINA B | Director | Buy | M | 2.75 | 10,000 | 27,500 | 36,886 | 26.9 K to 36.9 K (+37.19 %) |
Jan 05 2004 | ENZN | ENZON PHARMACEUTIC ... | PARKINSON ROBERT L JR | Director | Option Exercise | A | 12.15 | 5,000 | 60,750 | 5,000 | |
Jan 05 2004 | ENZN | ENZON PHARMACEUTIC ... | PARKINSON ROBERT L JR | Director | Option Exercise | A | 0.00 | 293 | 0 | 293 | |
Jan 05 2004 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Option Exercise | A | 12.15 | 5,000 | 60,750 | 5,000 | |
Jan 05 2004 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Option Exercise | A | 0.00 | 335 | 0 | 335 | |
Jan 05 2004 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Option Exercise | A | 12.15 | 5,000 | 60,750 | 5,000 | |
Jan 05 2004 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Option Exercise | A | 0.00 | 335 | 0 | 335 | |
Jan 05 2004 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Option Exercise | A | 12.15 | 5,000 | 60,750 | 5,000 | |
Jan 05 2004 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Option Exercise | A | 0.00 | 335 | 0 | 335 | |
Jan 05 2004 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Option Exercise | A | 12.15 | 5,000 | 60,750 | 5,000 | |
Jan 05 2004 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Option Exercise | A | 0.00 | 293 | 0 | 293 | |
Jan 05 2004 | ENZN | ENZON PHARMACEUTIC ... | BARLOW DAVID S | Director | Option Exercise | A | 0.00 | 209 | 0 | 209 | |
Oct 02 2003 | ENZN | ENZON PHARMACEUTIC ... | DIXON ROSINA B | Director | Option Exercise | A | 0.00 | 301 | 0 | 301 | |
Oct 02 2003 | ENZN | ENZON PHARMACEUTIC ... | DIXON ROSINA B | Director | Option Exercise | A | 0.00 | 301 | 0 | 301 | |
Oct 02 2003 | ENZN | ENZON PHARMACEUTIC ... | DIXON ROSINA B | Director | Option Exercise | A | 0.00 | 301 | 0 | 301 | |
Oct 02 2003 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Option Exercise | A | 0.00 | 344 | 0 | 344 | |
Oct 02 2003 | ENZN | ENZON PHARMACEUTIC ... | BARLOW DAVID S | Director | Option Exercise | A | 0.00 | 344 | 0 | 344 | |
Oct 02 2003 | ENZN | ENZON PHARMACEUTIC ... | PARKINSON ROBERT L JR | Director | Option Exercise | A | 0.00 | 301 | 0 | 301 | |
Oct 02 2003 | ENZN | ENZON PHARMACEUTIC ... | CLASSON ROLF A | Director | Option Exercise | A | 0.00 | 387 | 0 | 387 | |
Oct 02 2003 | ENZN | ENZON PHARMACEUTIC ... | GOLDE DAVID | Director | Option Exercise | A | 0.00 | 258 | 0 | 258 |